Team Evans and Watkins: Excitatory Amino Acid research at Bristol University 1973-1981.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
15 10 2021
Historique:
pubmed: 30 8 2021
medline: 5 2 2022
entrez: 29 8 2021
Statut: ppublish

Résumé

A series of Special Issues of Neuropharmacology celebrates the 40th anniversary of a seminal review on excitatory amino acid (EAA) receptors by two pioneers of the field - Dick Evans and Jeff Watkins. Brought together in the Department of Pharmacology at the University of Bristol in the 1970s, they forged a partnership that, through the synthetic chemistry prowess of Jeff Watkins, which provided novel agonists and antagonists for EAA receptors for Dick Evans's deft experimental studies, generated enormous insight into the multitude of actions of EAAs in the nervous system. Among many achievements from this time was not just the naming of the N-methyl-d-aspartate (NMDA) receptor, but also the demonstration of its antagonism by magnesium ions. Here, Dick and Jeff reflect upon those early halcyon days of EAA research, which, as these six

Identifiants

pubmed: 34454911
pii: S0028-3908(21)00323-3
doi: 10.1016/j.neuropharm.2021.108768
pii:
doi:

Substances chimiques

Excitatory Amino Acid Antagonists 0
Excitatory Amino Acids 0
Receptors, Glutamate 0

Types de publication

Editorial Historical Article Introductory Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108768

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Richard H Evans (RH)

Formerly of: The Department of Pharmacology, The Medical School, The University of Bristol, University Walk, Bristol, BS8 1TD, UK.

Jeffrey C Watkins (JC)

Formerly of: The Department of Pharmacology, The Medical School, The University of Bristol, University Walk, Bristol, BS8 1TD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH